Belize vs Oman: Statin use vs. average non-HDL cholesterol levels

Belize

3.4

in 2018

Oman

3.4

in 2018

Belize rank

75th

Oman rank

75th

Statin use vs. average non-HDL cholesterol levels over time

Belize
Oman

How they compare

Belize currently reports 3.4 against 3.4 in Oman, a difference of 0.

The two have swapped places 1 time across 39 shared years of data; in 1980 it was Belize ahead.

Belize ranks 75th and Oman ranks 75th of 191 countries.

Individual pages

About this data

Indicator: Statin use vs. average non-HDL cholesterol levels
Source: World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data
Licence: CC BY 4.0 (Our World in Data)
Coverage: 191 places, 7,449 data points, 1980–2018
Last refreshed: 07 August 2026

The use of statins in the population. This is compared to average non-HDL cholesterol levels, in mmol/L. Statins are a type of drug that reduce non-HDL cholesterol levels, and are used to treat and prevent cardiovascular diseases in people at heightened risk. Their usage is measured in Defined Daily Doses, per 1,000 people.